A comprehensive spatio-cellular map of the human hypothalamus, Tadros, 2025

ME/CFS Science Blog

Senior Member (Voting Rights)
The hypothalamus is a brain region that plays a key role in coordinating fundamental biological functions1. However, our understanding of the underlying cellular components and neurocircuitries have, until recently, emerged primarily from rodent studies2,3. Here we combine single-nucleus sequencing of 433,369 human hypothalamic cells with spatial transcriptomics, generating a comprehensive spatio-cellular transcriptional map of the hypothalamus, the ‘HYPOMAP’. Although conservation of neuronal cell types between humans and mice, as based on transcriptomic identity, is generally high, there are notable exceptions. Specifically, there are significant disparities in the identity of pro-opiomelanocortin neurons and in the expression levels of G-protein-coupled receptors between the two species that carry direct implications for currently approved obesity treatments. Out of the 452 hypothalamic cell types, we find that 291 neuronal clusters are significantly enriched for expression of body mass index (BMI) genome-wide association study genes. This enrichment is driven by 426 ‘effector’ genes. Rare deleterious variants in six of these (MC4R, PCSK1, POMC, CALCR, BSN and CORO1A) associate with BMI at population level, and CORO1A has not been linked previously to BMI. Thus, HYPOMAP provides a detailed atlas of the human hypothalamus in a spatial context and serves as an important resource to identify new druggable targets for treating a wide range of conditions, including reproductive, circadian and metabolic disorders.
Source: A comprehensive spatio-cellular map of the human hypothalamus | Nature

I've tested ME/CFS enrichment for cell types in the hypothalamus using DecodeME and this dataset called HYPOMAP.

It did single cell RNA sequencing on 433,369 hypothalamic cells from 11 donors.
They organized the data into 452 cell types (the finest grouping C4) but there are also broader grouping categories (C0, C1, C2, C3).

The raw data (5.2 GB)) is available here in HDF5 format:
HYPOMAP: A comprehensive spatio-cellularmap of the human hypothalamus - CZ CELLxGENE Discover

It was a bit tricky to load this big dataset and prepare it for MAGMA analysis but I think I've managed with the help of AI. Here's what I did:

- calculate CPM: each gene's count in a nucleus is divided by the nucleus's total * 1 million
- take log2(CPM + 1) so that large values don't dominate
- Take the mean per C4 cell type
- Take the average across all the C4 cell types to add as a covariate in MAGMA

This is what the results look like for 452 cell types. They are grouped on the X-axis per C1 cluster which I think refers to location or position in the hypothalamus. None of the cell-types came close to statistical significance. I think the Mid-2 GLU-2 ARHGAP42 SHISAL2B might be at the top because of random fluctuation. It had relatively few cells and similar cell types reached lower p-values.

1794766445076.webp

I also ran the analysis for the other grouping levels. The lowest p-value was for the 13 groups of C1 where the GABA-neurons in the Pre-1 group reached a p-value of 0.0056.

1794766957551.webp
 
I also ran the analysis for the other grouping levels. The lowest p-value was for the 13 groups of C1 where the GABA-neurons in the Pre-1 group reached a p-value of 0.0056.
They don't give a good explanation of what that C1-5 Pre-1 cluster is. They only give top markers in supplementary sheet 6:

MEIS2
PPP1R1B
CXCL14
SH3RF2
DRD1

When I searched what these markers were, they seem to be markers of medium spiny neurons, especially DRD1 and PPP1R1B. Wouldn't surprise me if Pre-1 is an intersection or mix with cells from the striatum.
 
This entire dataset is from the hypothalamus and our analysis uses the average expression as a covariate. So it isn't answering the question if the hypothalamus forms a good match for ME/CFS. It's more like ranking the different hypothalamic cell types against each other (and none seem to stick out).

The fact that striatum-like cells score relatively high as a group does seem to suggest that hypothalamus cells might not form a great match with DecodeME genes, compared to the MSN from the striatum.
 
How hard would it be to run this analysis for narcolepsy gene enrichment? Thinking it might be interesting to see these graphs for a disease where we're confident the hypothalamus is affected.

(Though on the other hand I know the biggest signal in the narcolepsy GWAS is more immune so maybe we wouldn't expect to see much for narcolepsy here either).
 
Back
Top Bottom